LBRX
LB Pharmaceuticals Inc Common Stock
NASDAQ: LBRX · HEALTHCARE · BIOTECHNOLOGY
$31.71
+3.66% today
Updated 2026-04-30
Market cap
$912.17M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.13
Dividend yield
—
52W range
$13 – $33
Volume
0.3M
LB Pharmaceuticals Inc Common Stock (LBRX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 3
Last 3 quarters
Avg EPS surprise
-47.7%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.7%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-5.2%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-25 | $-0.45 | +22.4% | $24.75 | $24.23 | -2.1% |
| 2025-11-06 | $-0.61 | -117.9% | $16.20 | $15.35 | -5.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.58 | $-0.45 | +22.4% | — | — |
| 2025-09-30 | $-0.28 | $-0.61 | -117.9% | — | — |
| 2025-06-30 | $0.00 | $-1.44 | — | — | — |
Frequently asked questions
Has LB Pharmaceuticals Inc Common Stock beaten earnings estimates?
LB Pharmaceuticals Inc Common Stock has beaten Wall Street EPS estimates in 1 of its last 3 quarterly reports, with an average EPS surprise of -47.7% over the last 2 quarters.
How does LBRX stock react to earnings?
LBRX stock has moved an average of -3.7% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.